Repurposing of FDA-approved drugs against cancer – focus on metastasis

Béla Ozsvári¹, Rebecca Lamb¹, Michael P. Lisanti¹

¹The Breast Cancer Now Research Unit, Institute of Cancer Sciences, CRUK Manchester Institute, University of Manchester, UK

Received: February 9, 2016Accepted: March 31, 2016Published: April 2, 2016

Copyright: © 2016 Ozsvári et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.